GC Genome Corporation

₩6,910As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:340450Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 7.05%
Biotechnology
Beta (5Y) —
PE TTM 30.07
TSR TTM (2.95%)
Mkt cap ₩163.4B
ROIC 3.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩8,465
22.51%
(90.66%)
Hold 5|2|3|7|6
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
80.79
80.09
88.93
84.49
21.77%
13.41%
29.54%
15.30%
Revenue₩B
8.621
8.727
8.836
9.346
9.87%
5.92%
5.22%
5.96%
Peers (US$120.5M)
Cap (US$)
PE
117.6M
—
Capital
TTM
5Y
10Y
Leveragex
0.508
—
—
EBIT/Intx
0.512
0.378
0.370
Own earn%
211.84
(15.45)
(19.58)
Sh yield%
15.39
45.28
47.86
Owners
Insiders/Inst%
9.73
48.56
Short interest%
4.91
SBC / revenue%
5.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
3–9
$1 testx
1.1
Incr. ROIC%
53